{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:40:42Z","timestamp":1787002842141,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1038\/s41440-023-01503-8","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T08:01:45Z","timestamp":1699862505000},"page":"944-958","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["The impact of superselective adrenal artery embolization on renal function in patients with primary aldosteronism: a prospective cohort study"],"prefix":"10.1038","volume":"47","author":[{"given":"Ze-Qun","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning-Peng","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"1503_CR1","first-page":"2854","volume":"85","author":"KC Loh","year":"2000","unstructured":"Loh KC, Koay ES, Khaw MC, Emmanuel SC, Young WF Jr. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab. 2000;85:2854\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1503_CR2","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","volume":"69","author":"S Monticone","year":"2017","unstructured":"Monticone S, Burrello J, Tizzani D, Bertello C, Viola A, Buffolo F, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69:1811\u201320.","journal-title":"J Am Coll Cardiol"},{"key":"1503_CR3","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, et al. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293\u2013300.","journal-title":"J Am Coll Cardiol"},{"key":"1503_CR4","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","volume":"40","author":"DA Calhoun","year":"2002","unstructured":"Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension. 2002;40:892\u20136.","journal-title":"Hypertension."},{"key":"1503_CR5","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"1503_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Desideri G, Fabris B, Ferri C, Giacchetti G, et al. Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension. 2006;48:232\u20138.","journal-title":"Hypertension."},{"key":"1503_CR7","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1001\/jama.295.22.2638","volume":"295","author":"LA Sechi","year":"2006","unstructured":"Sechi LA, Novello M, Lapenna R, Baroselli S, Nadalini E, Colussi GL, et al. Long-term renal outcomes in patients with primary aldosteronism. JAMA. 2006;295:2638\u201345.","journal-title":"JAMA."},{"key":"1503_CR8","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1681\/ASN.2004100878","volume":"16","author":"J Ribstein","year":"2005","unstructured":"Ribstein J, Du Cailar G, Fesler P, Mimran A. Relative glomerular hyperfiltration in primary aldosteronism. J Am Soc Nephrol. 2005;16:1320\u20135.","journal-title":"J Am Soc Nephrol"},{"key":"1503_CR9","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.2174\/1381612825666190311130138","volume":"24","author":"K Stavropoulos","year":"2018","unstructured":"Stavropoulos K, Papadopoulos C, Koutsampasopoulos K, Lales G, Mitas C, Doumas M. Mineralocorticoid receptor antagonists in primary aldosteronism. Curr Pharm Des. 2018;24:5508\u201316.","journal-title":"Curr Pharm Des"},{"key":"1503_CR10","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.1210\/jc.2018-00059","volume":"103","author":"M Takeda","year":"2018","unstructured":"Takeda M, Yamamoto K, Akasaka H, Rakugi H, Naruse M, Takeda Y, et al. Clinical characteristics and postoperative outcomes of primary aldosteronism in the elderly. J Clin Endocrinol Metab. 2018;103:3620\u201329.","journal-title":"J Clin Endocrinol Metab"},{"key":"1503_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","volume":"5","author":"TA Williams","year":"2017","unstructured":"Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5:689\u201399.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1503_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.cjca.2020.05.013","volume":"37","author":"D Sam","year":"2021","unstructured":"Sam D, Kline GA, So B, Przybojewski SJ, Leung AA. Unilateral disease is common in patients with primary aldosteronism without adrenal nodules. Can J Cardiol. 2021;37:269\u201375.","journal-title":"Can J Cardiol"},{"key":"1503_CR13","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1210\/jc.2003-031337","volume":"89","author":"P Mulatero","year":"2004","unstructured":"Mulatero P, Stowasser M, Loh KC, Fardella CE, Gordon RD, Mosso L, et al. Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab. 2004;89:1045\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"1503_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1148\/radiol.2272011798","volume":"227","author":"H Hokotate","year":"2003","unstructured":"Hokotate H, Inoue H, Baba Y, Tsuchimochi S, Nakajo M. Aldosteronomas: experience with superselective adrenal arterial embolization in 33 cases. Radiology. 2003;227:401\u20136.","journal-title":"Radiology."},{"key":"1503_CR15","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/MED.0000000000000329","volume":"24","author":"BA Sacks","year":"2017","unstructured":"Sacks BA, Sacks AC, Faintuch S. Radiofrequency ablation treatment for aldosterone-producing adenomas. Curr Opin Endocrinol Diabetes Obes. 2017;24:169\u201373.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"1503_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.2214\/AJR.12.9507","volume":"201","author":"AM Fowler","year":"2013","unstructured":"Fowler AM, Burda JF, Kim SK. Adrenal artery embolization: anatomy, indications, and technical considerations. AJR Am J Roentgenol. 2013;201:190\u2013201.","journal-title":"AJR Am J Roentgenol"},{"key":"1503_CR17","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/ccd.29554","volume":"97","author":"H Dong","year":"2021","unstructured":"Dong H, Zou Y, He J, Deng Y, Chen Y, Song L, et al. Superselective adrenal arterial embolization for idiopathic hyperaldosteronism: 12-month results from a proof-of-principle trial. Catheter Cardiovas Interv. 2021;97:976\u201381.","journal-title":"Catheter Cardiovas Interv"},{"key":"1503_CR18","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/s41440-023-01236-8","volume":"46","author":"J Qiu","year":"2023","unstructured":"Qiu J, Li N, Xiong HL, Yang J, Li YD, Hu CK, et al. Superselective adrenal arterial embolization for primary aldosteronism without lateralized aldosterone secretion: an efficacy and safety, proof-of-principle study. Hypertens Res. 2023;46:1297\u2013310.","journal-title":"Hypertens Res"},{"key":"1503_CR19","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1210\/jc.2008-1851","volume":"94","author":"M Reincke","year":"2009","unstructured":"Reincke M, Rump LC, Quinkler M, Hahner S, Diederich S, Lorenz R, et al. Risk factors associated with a low glomerular filtration rate in primary aldosteronism. J Clin Endocrinol Metab. 2009;94:869\u201375.","journal-title":"J Clin Endocrinol Metab"},{"key":"1503_CR20","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1210\/jc.2008-2245","volume":"94","author":"LA Sechi","year":"2009","unstructured":"Sechi LA, Di Fabio A, Bazzocchi M, Uzzau A, Catena C. Intrarenal hemodynamics in primary aldosteronism before and after treatment. J Clin Endocrinol Metab. 2009;94:1191\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"1503_CR21","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1210\/jc.2013-2180","volume":"99","author":"Y Iwakura","year":"2014","unstructured":"Iwakura Y, Morimoto R, Kudo M, Ono Y, Takase K, Seiji K, et al. Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases. J Clin Endocrinol Metab. 2014;99:1593\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1503_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","volume":"63","author":"GP Rossi","year":"2014","unstructured":"Rossi GP, Auchus RJ, Brown M, Lenders JW, Naruse M, Plouin PF, et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension. 2014;63:151\u201360.","journal-title":"Hypertension."},{"key":"1503_CR23","unstructured":"Zhu JR, Gao RL, Zhao SP, Lu GP, Zhao D, Li JJ, et al. Guidelines for prevention and treatment of dyslipidemia in Chinese adults (2016 version). Chinese Circulation Journal. 2016;31:937\u201353, (in chinese)."},{"key":"1503_CR24","unstructured":"Mellitus CCGftPaTosd. Clinical Guidelines for Prevention and Treatment of Type 2 Diabetes Mellitus in the Elderly in China (2022 Edition). Chinese Journal of Diabetes. 2022;30:2\u201351."},{"key":"1503_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","volume":"139","author":"AS Levey","year":"2003","unstructured":"Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137\u201347.","journal-title":"Ann Intern Med"},{"key":"1503_CR26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.kint.2019.02.021","volume":"96","author":"C Rowe","year":"2019","unstructured":"Rowe C, Sitch AJ, Barratt J, Brettell EA, Cockwell P, Dalton RN, et al. Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease. Kidney Int. 2019;96:429\u201335.","journal-title":"Kidney Int"},{"key":"1503_CR27","doi-asserted-by":"crossref","unstructured":"Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311:2518\u201331.","DOI":"10.1001\/jama.2014.6634"},{"key":"1503_CR28","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.atherosclerosis.2023.01.016","volume":"369","author":"SS Kwon","year":"2023","unstructured":"Kwon SS, Lee H, Park BW, Kwon SH, Bang DW, Jeon JS, et al. Association of glomerular hyperfiltration with carotid artery plaque in the general population. Atherosclerosis. 2023;369:30\u201336.","journal-title":"Atherosclerosis."},{"key":"1503_CR29","doi-asserted-by":"publisher","first-page":"845","DOI":"10.2337\/dc22-2003","volume":"46","author":"D Moriconi","year":"2023","unstructured":"Moriconi D, Sacchetta L, Chiriaco M, Nesti L, Forotti G, Natali A, et al. Glomerular hyperfiltration predicts kidney function decline and mortality in Type 1 and Type 2 diabetes: a 21-year longitudinal study. Diabetes Care. 2023;46:845\u201353.","journal-title":"Diabetes Care"},{"key":"1503_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1055\/s-2007-971196","volume":"24","author":"MW D\u2019Angelo","year":"2007","unstructured":"D\u2019Angelo MW. Transcatheter alcohol embolization of an aldosteronoma. Semin Interv Radio. 2007;24:96\u20139.","journal-title":"Semin Interv Radio"},{"key":"1503_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.radcr.2016.10.013","volume":"12","author":"JT Salsamendi","year":"2017","unstructured":"Salsamendi JT, Gortes FJ, Ayala AR, Palacios JD, Tewari S, Narayanan G. Transarterial embolization of a hyperfunctioning aldosteronoma in a patient with bilateral adrenal nodules. Radio Case Rep. 2017;12:87\u201391.","journal-title":"Radio Case Rep."},{"key":"1503_CR32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.radcr.2022.01.043","volume":"17","author":"IS Van der Walt","year":"2022","unstructured":"Van der Walt IS, Brown M, Lodh S. Adrenal gland-sparing transcatheter embolisation of an aldosteronoma for the treatment of refractory hypertension. Radio Case Rep. 2022;17:1088\u201394.","journal-title":"Radio Case Rep."},{"key":"1503_CR33","doi-asserted-by":"publisher","first-page":"1013426","DOI":"10.3389\/fcvm.2022.1013426","volume":"9","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Wang D, Liu Q, Hou J, Wang P. Case report: percutaneous adrenal arterial embolization cures resistant hypertension. Front Cardiovasc Med. 2022;9:1013426.","journal-title":"Front Cardiovasc Med"},{"key":"1503_CR34","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2169\/internalmedicine.55.5196","volume":"55","author":"M Kometani","year":"2016","unstructured":"Kometani M, Yoneda T, Demura M, Karashima S, Mori S, Oe M, et al. The long-term effect of adrenal arterial embolization for unilateral primary aldosteronism on cardiorenovascular protection, blood pressure, and the endocrinological profile. Intern Med. 2016;55:769\u201373.","journal-title":"Intern Med"},{"key":"1503_CR35","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.2214\/ajr.168.5.9129420","volume":"168","author":"H Inoue","year":"1997","unstructured":"Inoue H, Nakajo M, Miyazono N, Nishida H, Ueno K, Hokotate H. Transcatheter arterial ablation of aldosteronomas with high-concentration ethanol: preliminary and long-term results. AJR Am J Roentgenol. 1997;168:1241\u20135.","journal-title":"AJR Am J Roentgenol"},{"key":"1503_CR36","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/jch.13960","volume":"22","author":"H Zhang","year":"2020","unstructured":"Zhang H, Li Q, Liu X, Zhao Z, He H, Sun F, et al. Adrenal artery ablation for primary aldosteronism without apparent aldosteronoma: an efficacy and safety, proof-of-principle trial. J Clin Hypertens. 2020;22:1618\u201326.","journal-title":"J Clin Hypertens"},{"key":"1503_CR37","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1093\/ajh\/hpac105","volume":"35","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Liu Q, Wang X, Wan J, Liu S, Luo T, et al. Adrenal ablation versus mineralocorticoid receptor antagonism for the treatment of primary aldosteronism: a single-center prospective cohort study. Am J Hypertens. 2022;35:1014\u201323.","journal-title":"Am J Hypertens"},{"key":"1503_CR38","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41440-022-01034-8","volume":"46","author":"F Sun","year":"2023","unstructured":"Sun F, Liu X, Zhang H, Zhou X, Zhao Z, He H, et al. Catheter-based adrenal ablation: an alternative therapy for patients with aldosterone-producing adenoma. Hypertens Res. 2023;46:91\u201399.","journal-title":"Hypertens Res"},{"key":"1503_CR39","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/CIRCULATIONAHA.121.054318","volume":"144","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Liu X, Zhang H, Li Q, He H, Yan Z, et al. Catheter-based adrenal ablation remits primary aldosteronism: a randomized medication-controlled trial. Circulation. 2021;144:580\u201382.","journal-title":"Circulation."},{"key":"1503_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jfma.2018.01.006","volume":"118","author":"KH Huang","year":"2019","unstructured":"Huang KH, Yu CC, Hu YH, Chang CC, Chan CK, Liao SC, et al. Targeted treatment of primary aldosteronism - The consensus of Taiwan Society of Aldosteronism. J Formos Med Assoc. 2019;118:72\u201382.","journal-title":"J Formos Med Assoc"},{"key":"1503_CR41","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1161\/01.HYP.10.1.11","volume":"10","author":"G Kimura","year":"1987","unstructured":"Kimura G, Saito F, Kojima S, Yoshimi H, Abe H, Kawano Y, et al. Renal function curve in patients with secondary forms of hypertension. Hypertension. 1987;10:11\u20135.","journal-title":"Hypertension."},{"key":"1503_CR42","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12020-016-0983-9","volume":"54","author":"C Adolf","year":"2016","unstructured":"Adolf C, Asbach E, Dietz AS, Lang K, Hahner S, Quinkler M, et al. Worsening of lipid metabolism after successful treatment of primary aldosteronism. Endocrine. 2016;54:198\u2013205.","journal-title":"Endocrine."},{"key":"1503_CR43","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/jch.12914","volume":"19","author":"BJ Kramers","year":"2017","unstructured":"Kramers BJ, Kramers C, Lenders JW, Deinum J. Effects of treating primary aldosteronism on renal function. J Clin Hypertens. 2017;19:290\u201395.","journal-title":"J Clin Hypertens"},{"key":"1503_CR44","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00345-017-2033-5","volume":"35","author":"T Utsumi","year":"2017","unstructured":"Utsumi T, Kamiya N, Kaga M, Endo T, Yano M, Kamijima S, et al. Development of novel nomograms to predict renal functional outcomes after laparoscopic adrenalectomy in patients with primary aldosteronism. World J Urol. 2017;35:1577\u201383.","journal-title":"World J Urol"},{"key":"1503_CR45","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1161\/HYPERTENSIONAHA.119.13131","volume":"74","author":"H Kobayashi","year":"2019","unstructured":"Kobayashi H, Abe M, Nakamura Y, Takahashi K, Fujita M, Takeda Y, et al. Association between acute fall in estimated glomerular filtration rate after treatment for primary aldosteronism and long-term decline in renal function. Hypertension. 2019;74:630\u201338.","journal-title":"Hypertension."},{"key":"1503_CR46","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/iju.13844","volume":"26","author":"T Onohara","year":"2019","unstructured":"Onohara T, Takagi T, Yoshida K, Iizuka J, Okumi M, Kondo T, et al. Assessment of postoperative renal function after adrenalectomy in patients with primary aldosteronism. Int J Urol. 2019;26:229\u201333.","journal-title":"Int J Urol"},{"key":"1503_CR47","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/iju.14905","volume":"29","author":"YC Lu","year":"2022","unstructured":"Lu YC, Liu KL, Wu VC, Wang SM, Lin YH, Chueh SJ, et al. Factors associated with renal function change after unilateral adrenalectomy in patients with primary aldosteronism. Int J Urol. 2022;29:831\u201337.","journal-title":"Int J Urol"},{"key":"1503_CR48","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1161\/01.HYP.35.3.822","volume":"35","author":"TA Kotchen","year":"2000","unstructured":"Kotchen TA, Piering AW, Cowley AW, Grim CE, Gaudet D, Hamet P, et al. Glomerular hyperfiltration in hypertensive African Americans. Hypertension. 2000;35:822\u201326.","journal-title":"Hypertension."}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01503-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01503-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01503-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T19:04:01Z","timestamp":1712257441000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-023-01503-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,13]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1503"],"URL":"https:\/\/doi.org\/10.1038\/s41440-023-01503-8","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,13]]},"assertion":[{"value":"14 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}